Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP474852.RAcYgUHL11h4qYnl819GZafBrau2B2fsAY5jwBrR7PNcQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP474852.RAcYgUHL11h4qYnl819GZafBrau2B2fsAY5jwBrR7PNcQ130_assertion type Assertion NP474852.RAcYgUHL11h4qYnl819GZafBrau2B2fsAY5jwBrR7PNcQ130_head.
- NP474852.RAcYgUHL11h4qYnl819GZafBrau2B2fsAY5jwBrR7PNcQ130_assertion description "[Therefore, AAV-HGFK1+Ad-p53 cocktail therapy has a significantly higher therapeutic effect than AAV-HGFK1 or Ad-p53 alone and is a novel promising gene therapy for colon cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP474852.RAcYgUHL11h4qYnl819GZafBrau2B2fsAY5jwBrR7PNcQ130_provenance.
- NP474852.RAcYgUHL11h4qYnl819GZafBrau2B2fsAY5jwBrR7PNcQ130_assertion evidence source_evidence_literature NP474852.RAcYgUHL11h4qYnl819GZafBrau2B2fsAY5jwBrR7PNcQ130_provenance.
- NP474852.RAcYgUHL11h4qYnl819GZafBrau2B2fsAY5jwBrR7PNcQ130_assertion SIO_000772 18790766 NP474852.RAcYgUHL11h4qYnl819GZafBrau2B2fsAY5jwBrR7PNcQ130_provenance.
- NP474852.RAcYgUHL11h4qYnl819GZafBrau2B2fsAY5jwBrR7PNcQ130_assertion wasDerivedFrom befree-20140225 NP474852.RAcYgUHL11h4qYnl819GZafBrau2B2fsAY5jwBrR7PNcQ130_provenance.
- NP474852.RAcYgUHL11h4qYnl819GZafBrau2B2fsAY5jwBrR7PNcQ130_assertion wasGeneratedBy ECO_0000203 NP474852.RAcYgUHL11h4qYnl819GZafBrau2B2fsAY5jwBrR7PNcQ130_provenance.